These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 9435798)

  • 21. Aging and cancer: are telomeres and telomerase the connection?
    Shay JW
    Mol Med Today; 1995 Nov; 1(8):378-84. PubMed ID: 9415184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
    Engelhardt M; Martens UM
    Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase activity in human cancer.
    Shay JW; Wright WE
    Curr Opin Oncol; 1996 Jan; 8(1):66-71. PubMed ID: 8868103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase and telomere dynamics in ageing and cancer: current status and future directions.
    Sampedro Camarena F; Cano Serral G; Sampedro Santaló F
    Clin Transl Oncol; 2007 Mar; 9(3):145-54. PubMed ID: 17403625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of telomerase activity and telomere function in cancer.
    Gordon KE; Parkinson EK
    Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
    Klingelhutz AJ
    Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in telomerase activity and telomere length during human T lymphocyte senescence.
    Pan C; Xue BH; Ellis TM; Peace DJ; Díaz MO
    Exp Cell Res; 1997 Mar; 231(2):346-53. PubMed ID: 9087176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo regulation of telomerase activity and telomere length.
    Hathcock KS; Jeffrey Chiang Y; Hodes RJ
    Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase and cancer.
    Harley CB; Kim NW
    Important Adv Oncol; 1996; ():57-67. PubMed ID: 8791128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase inhibitors in cancer therapy: current status and future directions.
    Incles CM; Schultes CM; Neidle S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomere dysfunction and telomerase activation in cancer--a pathological paradox?
    Calcagnile O; Gisselsson D
    Cytogenet Genome Res; 2007; 118(2-4):270-6. PubMed ID: 18000380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physiopathologic implications of telomerase].
    Santos Ruiz A; Cascales Angosto M
    An R Acad Nac Med (Madr); 2000; 117(2):427-44; discussion 444-7. PubMed ID: 11209552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hallmarks of telomeres in ageing research.
    Shay JW; Wright WE
    J Pathol; 2007 Jan; 211(2):114-23. PubMed ID: 17200948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomeres and senescence: ending the debate.
    de Lange T
    Science; 1998 Jan; 279(5349):334-5. PubMed ID: 9454329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.